Théa Open Innovation

Théa Open Innovation is the dedicated corporate development and investment arm of Laboratoires Théa, the leading independent eye care group in Europe. The company focuses on sourcing, developing, and partnering for innovative ophthalmic treatments across all sub-specialties, including glaucoma, dry eye, and retinal diseases. By leveraging the extensive R&D and commercial infrastructure of its parent company, Théa Open Innovation provides a strategic pathway for biotech startups and academic researchers to bring novel therapies to the global market. Its portfolio includes a diverse range of modalities, from small molecules to advanced biologics and gene therapies. The entity acts as a bridge between early-stage innovation and global commercialization, offering financial support and technical expertise to its partners.